140. Dorabe syndrome
83 clinical trials,   54 drugs   (DrugBank: 13 drugs),   48 drug target genes,   62 drug target pathways

Searched query = "Dorabe syndrome", "Dravet syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04457687
(ClinicalTrials.gov)
November 9, 202030/6/2020Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory EpilepsiesExtended Access Program and Retrospective Chart Review for Lorcaserin in Dravet Syndrome and Other Refractory EpilepsiesEpilepsies, Myoclonic;Drug Resistant EpilepsyDrug: LorcaserinEisai Inc.NULLAvailable2 YearsN/AAllNULL
2NCT04572243
(ClinicalTrials.gov)
September 23, 202030/9/2020A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet SyndromeA Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet SyndromeEpilepsies, MyoclonicDrug: Placebo;Drug: LorcaserinEisai Inc.NULLRecruiting2 YearsN/AAll58Phase 3United States